Integration of the B-Cell Receptor Antigen Neurabin-I/SAMD14 Into an Antibody Format as New Therapeutic Approach for the Treatment of Primary CNS Lymphoma

por Bewarder, Moritz, Kiefer, Maximilian, Moelle, Clara, Goerens, Lisa, Stilgenbauer, Stephan, Christofyllakis, Konstantinos, Kaddu-Mulindwa, Dominic, Fadle, Natalie, Regitz, Evi, Neumann, Frank, Hoth, Markus, Preuss, Klaus-Dieter, Pfreundschuh, Michael, Thurner, Lorenz
Publicado 2020

Ars2‐containing bispecific, Fab‐ and IgG1‐format BAR‐bodies to target DLBCL cells

por Kiefer, Maximilian, Thurner, Lorenz, Bock, Theresa, Cetin, Onur, Kos, Igor, Lesan, Vadim, Kaddu‐Mulindwa, Dominic, Bittenbring, Joerg Thomas, Fadle, Natalie, Regitz, Evi, Hoth, Markus, Neumann, Frank, Preuss, Klaus‐Dieter, Pfreundschuh, Michael, Christofyllakis, Konstantinos, Bewarder, Moritz
Publicado 2022

The B-cell Receptor Autoantigen LRPAP1 Can Replace Variable Antibody Regions to Target Mantle Cell Lymphoma Cells

por Bewarder, Moritz, Kiefer, Maximilian, Will, Helene, Olesch, Kathrin, Moelle, Clara, Stilgenbauer, Stephan, Christofyllakis, Konstantinos, Kaddu-Mulindwa, Dominic, Bittenbring, Joerg Thomas, Fadle, Natalie, Regitz, Evi, Kaschek, Lea, Hoth, Markus, Neumann, Frank, Preuss, Klaus-Dieter, Pfreundschuh, Michael, Thurner, Lorenz
Publicado 2021